Related references
Note: Only part of the references are listed.Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets
A. H. Ellebedy et al.
VACCINE (2011)
Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic
Magali Lemaitre et al.
BMC INFECTIOUS DISEASES (2010)
Seasonal Influenza Vaccine and Increased Risk of Pandemic A/H1N1-Related Illness: First Detection of the Association in British Columbia, Canada
Naveed Z. Janjua et al.
CLINICAL INFECTIOUS DISEASES (2010)
Animal models for the preclinical evaluation of candidate influenza vaccines
Rogier Bodewes et al.
EXPERT REVIEW OF VACCINES (2010)
Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice
Rogier Bodewes et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Severity of Pneumonia Due to New H1N1 Influenza Virus in Ferrets Is Intermediate between That Due to Seasonal H1N1 Virus and Highly Pathogenic Avian Influenza H5N1 Virus
Judith M. A. van den Brand et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Multiple Infections with Seasonal Influenza A Virus Induce Cross-Protective Immunity against A(H1N1) Pandemic Influenza Virus in a Ferret Model
Karen L. Laurie et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
A Single Immunization with CoVaccine HT-Adjuvanted H5N1 Influenza Virus Vaccine Induces Protective Cellular and Humoral Immune Responses in Ferrets
R. Bodewes et al.
JOURNAL OF VIROLOGY (2010)
Large trials confirm immunogenicity of H1N1 vaccines
Heath Kelly et al.
LANCET (2010)
Vaccinate before the next pandemic?
Klaus Stoehr
NATURE (2010)
Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
Graeme E. Price et al.
PLOS ONE (2010)
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
Taia T. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17–18 February 2010
Marc P. Girard et al.
VACCINE (2010)
Association between the 2008-09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring-Summer 2009: Four Observational Studies from Canada
Danuta M. Skowronski et al.
PLOS MEDICINE (2010)
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
Claire S. Waddington et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
Michael Schotsaert et al.
EXPERT REVIEW OF VACCINES (2009)
Yearly influenza vaccinations: a double-edged sword?
Rogier Bodewes et al.
LANCET INFECTIOUS DISEASES (2009)
Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus
Rogier Bodewes et al.
PLOS ONE (2009)
MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
T. Vesikari et al.
VACCINE (2009)
Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus
J. H. C. M. Kreijtz et al.
VACCINE (2009)
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: Results of a phase I-II randomized clinical trial
Wendy A. Keitel et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
David I. Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Heterosubtypic immunity to influenza A virus: where do we stand?
Kristie M. Grebe et al.
MICROBES AND INFECTION (2008)
Report of the third meeting on “Influenza vaccines that induce broad spectrum and long-lasting immune responses”, World Health Organization, Geneva, Switzerland, 3–4 December 2007
Marc P. Girard et al.
VACCINE (2008)
Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development
Guus F. Rimmelzwaan et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans
Matthew R. Sandbulte et al.
PLOS MEDICINE (2007)
Avian influenza A (H5N1) age distribution in humans
Matthew Smallman-Raynor et al.
EMERGING INFECTIOUS DISEASES (2007)
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: An experiment of nature
SL Epstein
JOURNAL OF INFECTIOUS DISEASES (2006)
Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain
E de Wit et al.
JOURNAL OF VIROLOGY (2005)
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004
EA Govorkova et al.
JOURNAL OF VIROLOGY (2005)
Pathogenesis of avian influenza A (H5N1) viruses in ferrets
LA Zitzow et al.
JOURNAL OF VIROLOGY (2002)
The invasion routes of neurovirulent A Hong Kong 483/97 (H5N1) influenza virus into the central nervous system after respiratory infection in mice
CH Park et al.
ARCHIVES OF VIROLOGY (2002)
Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection
PP Heinen et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Pathogenesis of influenza A (H5N1) virus infection in a primate model
GF Rimmelzwaan et al.
JOURNAL OF VIROLOGY (2001)
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
KG Nicholson et al.
LANCET (2001)
Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells
KA Benton et al.
JOURNAL OF IMMUNOLOGY (2001)
Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets
SH Seo et al.
JOURNAL OF VIROLOGY (2001)
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes
HH Nguyen et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice
E O'Neill et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Share Paper
